Followers | 505 |
Posts | 10140 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
![](https://investorshub.advfn.com/uicon/475374.png?cb=1683825270)
Wednesday, July 23, 2014 2:07:56 PM
bullish
## source: finance.yahoo.com
Wed, 23 Jul 2014 17:25:43 GMT ~ Nasdaq stocks posting largest percentage decreases
[AP] - A look at the 10 biggest percentage decliners on Nasdaq at the close of trading: Ohr Pharmaceutical fell 32.1 percent to $7.74. Web.com Inc. fell 19.9 percent to $27.70. Aemetis Inc. fell 12.5 percent ...
read full: http://sg.finance.yahoo.com/news/nasdaq-stocks-posting-largest-percentage-220242625--finance.html
*********************************************************
Tue, 22 Jul 2014 15:51:00 GMT ~ 15 small-cap stocks Goldman Sachs says are worth a look
read full: http://www.marketwatch.com/News/Story/Story.aspx?guid=31604424-C2D4-D575-4454-C4C422D3B450&siteid=yhoof2
*********************************************************
Thu, 17 Jul 2014 12:56:00 GMT ~ An Unsolicited Comment On Janet Yellen's Biotech Comments
read full: http://www.forbes.com/sites/matthewherper/2014/07/17/an-unsolicited-comment-on-janet-yellen/?partner=yahootix
*********************************************************
Thu, 17 Jul 2014 09:30:00 GMT ~ Framing Up Capital Efficiency In Early Stage Biotech
read full: http://www.forbes.com/sites/brucebooth/2014/07/17/framing-up-capital-efficiency-in-early-stage-biotech/?partner=yahootix
*********************************************************
Tue, 15 Jul 2014 17:30:00 GMT ~ SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Agios Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty
[PR Newswire] - NEW YORK, July 15, 2014 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Agios Pharmaceuticals, Inc. (NasdaqGS: AGIO) in connection with possible claims of breaches of fiduciary duty by the board ...
read full: http://finance.yahoo.com/news/shareholder-alert-law-firm-levi-173000762.html
*********************************************************
$AGIO charts
basic chart ## source: stockcharts.com
basic chart ## source: eoddata.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AGIO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AGIO/company-info
Ticker: $AGIO
OTC Market Place: Not Available
CIK code: not found
Company name: Agios Pharmaceuticals, Inc.
Incorporated In:
Business Description:
$AGIO share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AGIO extra dd links
Company name: Agios Pharmaceuticals, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AGIO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AGIO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AGIO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/news - http://finance.yahoo.com/q/h?s=AGIO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AGIO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AGIO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AGIO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Agios+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Agios+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Agios+Pharmaceuticals%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AGIO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AGIO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AGIO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AGIO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AGIO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AGIO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AGIO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AGIO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AGIO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AGIO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AGIO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AGIO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AGIO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AGIO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AGIO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AGIO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AGIO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AGIO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AGIO
$AGIO DD Notes ~ http://www.ddnotesmaker.com/AGIO
jkflb
Recent AGIO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:15:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:12:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 09:15:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/08/2024 08:08:48 PM
- Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib • GlobeNewswire Inc. • 08/06/2024 09:50:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 01:49:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:03:30 AM
- Agios Reports Business Highlights and Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/01/2024 10:31:00 AM
- Agios Announces Results from Phase 3 ACTIVATE-KidsT Study of Mitapivat in Children with PK Deficiency Who Are Regularly Transfused • GlobeNewswire Inc. • 08/01/2024 10:30:00 AM
- Agios to Webcast Conference Call of Second Quarter 2024 Financial Results on August 1, 2024 • GlobeNewswire Inc. • 07/18/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:29:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:22:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:20:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:19:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:18:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 09:15:52 PM
- Agios Presents Positive Results from Phase 3 ENERGIZE Study of Mitapivat in Non-Transfusion-Dependent Thalassemia in Plenary Session at the European Hematology Association 2024 Hybrid Congress • GlobeNewswire Inc. • 06/15/2024 12:45:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:25:21 PM
- Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET • GlobeNewswire Inc. • 06/06/2024 01:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/05/2024 11:50:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:14:51 PM
- Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia • GlobeNewswire Inc. • 06/03/2024 10:30:00 AM
- Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 • GlobeNewswire Inc. • 05/30/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/28/2024 11:09:32 AM
- Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty • GlobeNewswire Inc. • 05/28/2024 11:00:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM